Ranbaxy Laboratories
Editor's Picks
There is no pinned content in this Editor's Picks module.
Click here to learn more about content pinning.
-
Buy Ranbaxy Laboratories for the target prices of Rs 514/519/Higher with a stop loss of Rs 500.5: ICICIDirect
Sify
We said, "weakness and close below the candle would attract more profit-booking." Index opened below the candle, and weakening further, closed below the candle with a net loss of 78 points or 0.4%. While most sectors enedd flat to negative, the... Full Article at Sify
-
7:13:59 AM India's largest drug maker Ranbaxy Laboratories plans to re-launch its former flagship skincare brand Sotret in the US, that has been banned for almost four years, through a marketing partnership with a Canadian firm Cipher Pharmaceuticals Ltd. Full Article at Biospace
-
Indian laboratory researchers conduct tests at the Ranbaxy Laboratories in Bombay, 07 April 2003. The tests are part of a preparatory plan to combat any possible outbreak of the Severe Acute Respiratory Syndrome (SARS) disease. View Photo »
-
ITC, Grasim Industries, Maruti, Ranbaxy Laboratories and Cipla appear strong while BHEL, Larsen & Toubro and GAIL might continue to underperform in the short term
SOURCE: Economic Times -
CII President Adi Godrej will be heading a 19-member CEOs delegation to Japan in this regard. Delegation members include Toyota Kirloskar Motor Vice-Chairman Vikram S Kirloskar, Accenture India Chairman and MD Avinash Vashistha and Ranbaxy Laboratories... Full Article at Business Standard
-
The copycat version was launched on the first day of patent expiry in the UK, they said in a statement late on Wednesday. Lipitor, chemically known as atorvastatin, is the world's top selling drug with market size of about $16 billion, they said. ... Full Article at MyDigitalFC.com | Financial Chronicle
-
The copycat version was launched on the first day of patent expiry in the UK, they said in a statement late on Wednesday. Lipitor, chemically known as atorvastatin, is the world's top selling drug with market size of about $16 billion, they said. ... Full Article at Reuters
-
-
A science graduate with a postgraduate diploma in management, Prasad began his career in 1984 as a management trainee with a Delhi-based company. In 1993, he joined Vorin Laboratories as general manager, marketing, and went on to become its managing... Full Article at Calcutta Telegraph
-
Post your opinion here Emkay Global Financial Services is bullish on Ranbaxy Laboratories and has recommended buy rating on the stock with a target price of Rs 559 in its May 09, 2012 research report. "Ranbaxy Laboratories, Q1CY12 Results - Revenues at... Full Article at Moneycontrol.com
-
Leading Indian drug manufacturer Ranbaxy Laboratories has boosted its presence in the emerging market of Africa, introducing its new malaria-fighting drug Synriam and setting up manufacturing facilities in Morocco, Nigeria and South Africa. The arrival... Full Article at GulfToday.ae
Related photos
About this topic
Wikipedia
There are no results for this module. Edit this module to change the search term used to query Wikipedia
Search Independent.ie topics
Related topics
Related videos
Related Conversations
Newsmap
See the geographical connection between Ranbaxy Laboratories and different parts of the world. Mouse over the map pins to explore connections.
There are no results for this module.
Sponsored Features
Highlights
Independentwoman.ie
Independent Woman
A fresh, fun site featuring celeb gossip, fashion, beauty, love & sex, and health & fitness.
- Independent Channels:
-
RSSLearn more...
-
MobileLearn more...
-
FacebookLearn more...
